The Valley Desk

ArticleBiotechnology journalPublished

Adaptation of an rVSV Ebola vaccine purification process for rapid development of a viral vaccine candidate for SARS-CoV-2

Read the publication ↗

Regional connection

Verified An author affiliation on the Europe PMC record names Merck & Co. Affiliation source

Institution
Merck & Co.

Publication record

Type
Article
Venue
Biotechnology journal
Published
Subject terms
Animals; Humans; Vesiculovirus; Hemorrhagic Fever, Ebola; Vaccines, Synthetic; Viral Vaccines; Ebola Vaccines; Antibodies, Viral; Ebolavirus; Vesicular stomatitis Indiana virus; Vesicular Stomatitis; Pandemics
PubMed ID
37766672
Added to directory
Source checked

Report a correction or request removal